Drugs / DCLL9718S
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03298516 | Nov 2017 → Jul 2019 | acute myeloid leukemia | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DCLL9718S | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03298516 ↗ |
| Route | Intravenous | “DCLL9718S intravenously (IV)” NCT03298516 ↗ |